Search research articles
Contact Us
Filters
Showing results (21-30 of 146) with videos related to
Page
of 15
Sort By:
Trends in Cancer
|
April 5, 2024
A big step for MYC-targeted therapies
Danielle F Atibalentja, Anja Deutzmann, Dean W Felsher
Immunologic Research
|
May 6, 2014
An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation
Stephanie C Casey, Yulin Li, Dean W Felsher
Nature Reviews. Cancer
|
March 25, 2010
MYC as a regulator of ribosome biogenesis and protein synthesis
Jan van Riggelen, Alper Yetil, Dean W Felsher
Blood
|
March 9, 2018
The MYC oncogene is a global regulator of the immune response
Stephanie C Casey, Virginie Baylot, Dean W Felsher
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2014
Addiction to multiple oncogenes can be exploited to prevent the emergence of therapeutic resistance
Peter S Choi, Yulin Li, Dean W Felsher
Advances in Experimental Medicine and Biology
|
November 13, 2012
Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs
David I Bellovin, Bikul Das, Dean W Felsher
Current Opinion in Immunology
|
April 11, 2013
Noncanonical roles of the immune system in eliciting oncogene addiction
Stephanie C Casey, David I Bellovin, Dean W Felsher
Methods in Molecular Biology (Clifton, N.J.)
|
May 21, 2021
Generation of a Tetracycline Regulated Mouse Model of MYC-Induced T-Cell Acute Lymphoblastic Leukemia
Wadie D Mahauad-Fernandez, Kavya Rakhra, Dean W Felsher
Cancer Research
|
August 17, 2005
Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression
Levi J Beverly, Dean W Felsher, Anthony J Capobianco
Aging
|
September 29, 2015
ARF: connecting senescence and innate immunity for clearance
Alper Y Kearney, Benedict Anchang, Sylvia Plevritis, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 146) with videos related to
Sort By:
Page
of 15
Trends in Cancer
|
April 5, 2024
A big step for MYC-targeted therapies
Danielle F Atibalentja, Anja Deutzmann, Dean W Felsher
Immunologic Research
|
May 6, 2014
An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation
Stephanie C Casey, Yulin Li, Dean W Felsher
Nature Reviews. Cancer
|
March 25, 2010
MYC as a regulator of ribosome biogenesis and protein synthesis
Jan van Riggelen, Alper Yetil, Dean W Felsher
Blood
|
March 9, 2018
The MYC oncogene is a global regulator of the immune response
Stephanie C Casey, Virginie Baylot, Dean W Felsher
Proceedings of the National Academy of Sciences of the United States of America
|
July 30, 2014
Addiction to multiple oncogenes can be exploited to prevent the emergence of therapeutic resistance
Peter S Choi, Yulin Li, Dean W Felsher
Advances in Experimental Medicine and Biology
|
November 13, 2012
Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs
David I Bellovin, Bikul Das, Dean W Felsher
Current Opinion in Immunology
|
April 11, 2013
Noncanonical roles of the immune system in eliciting oncogene addiction
Stephanie C Casey, David I Bellovin, Dean W Felsher
Methods in Molecular Biology (Clifton, N.J.)
|
May 21, 2021
Generation of a Tetracycline Regulated Mouse Model of MYC-Induced T-Cell Acute Lymphoblastic Leukemia
Wadie D Mahauad-Fernandez, Kavya Rakhra, Dean W Felsher
Cancer Research
|
August 17, 2005
Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression
Levi J Beverly, Dean W Felsher, Anthony J Capobianco
Aging
|
September 29, 2015
ARF: connecting senescence and innate immunity for clearance
Alper Y Kearney, Benedict Anchang, Sylvia Plevritis, et al.
Page
of 15